| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |